State of Wisconsin Investment Board’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-173,900
Closed -$548K 2057
2020
Q3
$548K Hold
173,900
﹤0.01% 1451
2020
Q2
$506K Hold
173,900
﹤0.01% 1427
2020
Q1
$490K Sell
173,900
-21,600
-11% -$69.6K ﹤0.01% 1358
2019
Q4
$634K Hold
195,500
﹤0.01% 1365
2019
Q3
$422K Hold
195,500
﹤0.01% 1380
2019
Q2
$614K Buy
195,500
+4,300
+2% +$13.9K ﹤0.01% 1267
2019
Q1
$711K Buy
191,200
+43,800
+30% +$148K ﹤0.01% 1247
2018
Q4
$427K Buy
147,400
+25,400
+21% +$69.8K ﹤0.01% 1360
2018
Q3
$321K Hold
122,000
﹤0.01% 1461
2018
Q2
$285K Hold
122,000
﹤0.01% 1402
2018
Q1
$359K Hold
122,000
﹤0.01% 1347
2017
Q4
$334K Hold
122,000
﹤0.01% 1347
2017
Q3
$414K Hold
122,000
﹤0.01% 1331
2017
Q2
$301K Buy
+122,000
New +$281K ﹤0.01% 1367

Other funds holding PDLI

State of Wisconsin Investment Board's PDLI Position: Q4 2020 in Review

State of Wisconsin Investment Board sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 173,900 shares — an estimated $548K sold.

State of Wisconsin Investment Board first reported a position in PDLI in Q2 2017 and held it in 14 quarters. The position peaked at $711K in Q1 2019. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • State of Wisconsin Investment Board reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 173,900 PDL BioPharma, Inc. shares in Q4 2020, an estimated $548K.
  • State of Wisconsin Investment Board first reported a position in PDL BioPharma, Inc. in Q2 2017 and held it in 14 quarters.
  • State of Wisconsin Investment Board's PDL BioPharma, Inc. position peaked at $711K in Q1 2019.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2020, filed 3 Feb 2021.